About Pricing FAQs Providers Trials Blog

Back to your record

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Breast Cancer Clinical Trials in Ohio | 986 Studies

Clinical Trials Breast CancerOhio

Breast Cancer Clinical Trials in Ohio

Find 986 clinical trials for breast cancer near Ohio. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Ohio

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 301-320 of 986 trials

CompletedMagnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast CancerRATIONALE: Magnesium oxide may help relieve hot flashes symptoms in women with a history of breast cancer.NCT01439945·Fairbanks, Alaska and 282 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingThe Ohio State University (OSU) SCREEN Community ProgramThis clinical trial develops and tests how well a multi-level intervention (MLI), The Ohio State University (OSU) SCREEN Community Program, works to increase screening and…NCT06666192·Columbus, Ohio

CompletedComparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00024102·Birmingham, Alabama and 333 others

CompletedRollover Study Of Lapatinib In Cancer PatientsThe EGF19060 study is a rollover study to evaluate the long term safety of lapatinib and to provide lapatinib to patients who had a positive response in previous lapatinib studies…NCT00169533·Indianapolis, Indiana and 11 others

TerminatedLonafarnib in Metastatic Breast CancerA published phase 2 study reported that lonafarnib was administered as a single agent via continuous or intermittent oral dosing to 76 women with advanced breast cancer who were…NCT00773474·Galesburg, Illinois and 5 others

Active not recruitingRandomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast CancerThe primary objective of this study is to demonstrate that the combination of palbociclib with anti-HER2 therapy plus endocrine therapy is superior to anti-HER2-based therapy plus…NCT02947685·San Francisco, California and 107 others

CompletedA Study of LY2523355 in Participants With Breast CancerThe purpose of the study is to evaluate the anti-tumor activity of LY2523355 relative to ixabepilone for the treatment of metastatic or locally recurrent breast cancer using…NCT01416389·Fort Myers, Florida and 11 others

RecruitingStudy of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast CancerThis is a multi-site, global, open-label study that includes a phase 1b evaluation of elacestrant in combination with abemaciclib in women and men with brain metastases from…NCT05386108·Fullerton, California and 85 others

CompletedThe Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast CancerThe purpose of this study is to compare the efficacy of Faslodex (fulvestrant) to Aromasin (exemestane) in hormone receptor positive postmenopausal women with advanced breast…NCT00065325·Birmingham, Alabama and 116 others

CompletedStudy Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast CancerThis is a world wide phase 1/2, open-label, study of neratinib in combination with capecitabine, conducted in 2 parts.NCT00741260·Mobile, Alabama and 36 others

UnknownStudy of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 SignalingThis is a prospective, single arm, open label, multicenter interventional study designed to evaluate the efficacy of neoadjuvant chemotherapy with anti-HER2 antibodies in patients…NCT03412643·Colton, California and 42 others

RecruitingStudy to Assess GTAEXS617 in Participants With Advanced Solid TumorsThe primary purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) and anti-tumor activity of GTAEXS617 (REC-617) in participants with advanced solid…NCT05985655·Los Angeles, California and 14 others

CompletedA Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)This first-in-human, open-label, multicenter, Phase Ia/Ib, adaptive, multiple ascending-dose study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics…NCT02627274·Tucson, Arizona and 25 others

CompletedComprehensive Gene Sequencing in Guiding Treatment Recommendations Patients With Metastatic or Recurrent Solid TumorsThis pilot clinical trial studies comprehensive gene sequencing in guiding treatment recommendations in patients with metastatic or recurrent solid tumors.NCT01987726·Columbus, Ohio

Active not recruitingS1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerRATIONALE: Estrogen can cause the growth of breast cancer cells.NCT01674140·Birmingham, Alabama and 1457 others

CompletedChanges in Breast Density and Blood Hormone Levels in Postmenopausal Women Receiving Anastrozole or Exemestane for Breast CancerRATIONALE: Studying changes in breast density and blood hormone levels in women receiving anastrozole or exemestane for breast cancer may help doctors learn more about the…NCT00516698·Augusta, Georgia and 179 others

Active not recruitingNeoadjuvant Pembrolizumab + Decitabine Followed by Std Neoadj Chemo for Locally Advanced HER2- Breast CaThis study is a 2-cohort, open-label, multicenter, phase 2 study of a short course of immunotherapy consisting of sequential decitabine followed by pembrolizumab administered…NCT02957968·Edgewood, Kentucky and 3 others

Active not recruitingTTX-080 HLA-G Antagonist in Subjects With Advanced CancersTTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerability, and recommended Phase 2 dose of TTX-080 monotherapy…NCT04485013·Tucson, Arizona and 40 others

RecruitingA Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF AlterationsThe objective of this Master Protocol is to evaluate the efficacy and safety of plixorafenib in participants with BRAF altered (BRAF V600E or BRAF fusions) locally advanced or…NCT05503797·Beverly Hills, California and 69 others

CompletedHormone Receptor Positive Metastatic Breast Cancer (HR+ mBC) BIIB021 Plus Aromasin Schedule FindingThe purpose of this study is to assess the efficacy, safety and tolerability of 2 dosing regimens of BIIB021 in combination with exemestane in women whose HR+ breast cancer had…NCT01004081·Alabaster, Alabama and 33 others

PreviousPage 16 of 50Next

Other Conditions in Ohio

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma